MASTROPASQUA, Mauro Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 3.995
EU - Europa 888
AS - Asia 518
SA - Sud America 62
AF - Africa 5
OC - Oceania 5
Totale 5.473
Nazione #
US - Stati Uniti d'America 3.982
SG - Singapore 263
SE - Svezia 255
IT - Italia 196
CN - Cina 171
RU - Federazione Russa 92
FR - Francia 91
GB - Regno Unito 68
BR - Brasile 57
DE - Germania 40
IN - India 33
UA - Ucraina 27
BE - Belgio 26
FI - Finlandia 22
IE - Irlanda 10
CA - Canada 9
IR - Iran 9
AT - Austria 6
ES - Italia 6
KR - Corea 6
NL - Olanda 6
RO - Romania 6
TR - Turchia 6
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
HK - Hong Kong 4
HR - Croazia 4
AU - Australia 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
HU - Ungheria 3
JP - Giappone 3
NP - Nepal 3
PL - Polonia 3
AR - Argentina 2
MD - Moldavia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AM - Armenia 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EC - Ecuador 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JO - Giordania 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MA - Marocco 1
MK - Macedonia 1
MT - Malta 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
QA - Qatar 1
SC - Seychelles 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
VN - Vietnam 1
Totale 5.473
Città #
Chandler 579
Fairfield 571
Ashburn 307
Woodbridge 277
Houston 262
Seattle 244
Wilmington 218
Nyköping 205
Cambridge 198
Singapore 162
Ann Arbor 134
Lawrence 112
Roxbury 91
Des Moines 69
Jacksonville 56
Paris 50
New York 42
Bari 41
San Diego 39
Beijing 36
Princeton 32
Nanjing 28
Brussels 26
Cressa 24
Pune 24
Los Angeles 23
Santa Clara 23
London 22
Falls Church 20
Inglewood 18
Boardman 15
Dearborn 14
Washington 14
Milan 13
San Mateo 13
Edinburgh 11
Dublin 10
Ardabil 9
Leawood 9
Augusta 7
Hebei 7
Hounslow 7
Amsterdam 6
Guangzhou 6
Nuremberg 6
Changsha 5
Fucecchio 5
Grafing 5
Hefei 5
Istanbul 5
Kilburn 5
Madrid 5
Toronto 5
Wuhan 5
Brooklyn 4
Chicago 4
Genoa 4
Hong Kong 4
Monmouth Junction 4
Nanchang 4
São Paulo 4
Taranto 4
Tianjin 4
Zagreb 4
Brasília 3
Budapest 3
Catania 3
Copenhagen 3
Dubai 3
Forlì 3
Frankfurt am Main 3
Montreal 3
Munich 3
Naples 3
New Bedfont 3
Scuola 3
Shanghai 3
Sofia 3
Spoltore 3
Tallinn 3
Tokyo 3
Vienna 3
Zhengzhou 3
Acton 2
Angri 2
Atlanta 2
Auckland 2
Barlassina 2
Belgrade 2
Bologna 2
Bucharest 2
Campinas 2
Chiswick 2
Curitiba 2
Dalian 2
Dallas 2
Denver 2
Florence 2
Fortaleza 2
Goiânia 2
Totale 4.256
Nome #
How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss working group of breast- and gynecopathologists 180
Analytical validation of a standardized scoring protocol for Ki67: Phase 3 of an international multicenter collaboration 146
A risk score based on histopathological features predicts higher risk of distant recurrence in premenopausal patients with lymph node-negative endocrine-responsive breast cancer 122
Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation 115
Inflammatory cells infiltrate and angiogenesis in locally advanced and metastatic cholangiocarcinoma 106
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial 100
A new technique for foetal brain fixation and extraction 91
Tumore a Cellule del Sertoli a Grandi Cellule Calcificante (TCSGCC) ad evoluzione maligna. Studio di un caso. 89
null 88
Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression 84
Adenomyoepithelioma 80
Paget's disease as a local recurrence after nipple-sparing mastectomy: Clinical presentation, treatment, outcome, and risk factor analysis 75
Pathological complete response after preoperative systemic therapy and outcome: Relevance of clinical and biologic baseline features 74
Ectopic breast tissue as a possible cause of false-positive axillary sentinel lymph node biopsies 72
Microscopic esophagitis and Barrett in endoscopy-negative gastroesophageal reflux disease (GERD) 70
Prognostic and predictive impact of central necrosis and fibrosis in early breast cancer. Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy 66
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial 66
BETA-GALACTOSYLCERAMIDASE PROMOTES MELANOMA GROWTH VIA MODULATION OF CERAMIDE METABOLISM 60
null 59
Basaloid cell carcinoma of the prostate. Case report and review of the literature 59
Mammary stereotaxic core-biopsy by Mammotome: an alternative to frozen section examination 58
Regulation of mRNA and protein levels of beta 1 integrin variants in human prostate carcinoma 57
null 57
A nomogram based on the expression of Ki-67, steroid hormone receptors status and number of chemotherapy courses to predict pathological complete remission after preoperative chemotherapy for breast cancer 57
Malignant Large Cell Calcifying Sertoli Cell Tumor of the Testis (LCCSCTT). Report of a case in an elderly man and review of the literature 56
How do the ASTRO consensus statement guidelines for the application of accelerated partial breast irradiation fit intraoperative radiotherapy? A retrospective analysis of patients treated at the European Institute of Oncology 56
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer 56
Survival outcomes in breast cancer patients with low estrogen/progesterone receptor expression 55
Abstract S4-6: An international Ki67 reproducibility study 55
Intra-Cystic (In Situ) Mucoepidermoid Carcinoma: A Clinico-Pathological Study of 14 Cases 55
Traditional molecular markers and response to adjuvant endocrine or trastuzumab-based therapies 54
Peri-Prostatic Epidermal Inclusion Cyst: A Case Report 54
Sensitivity and Detection Rate of a 12-Core Trans-Perineal Prostate Biopsy: Preliminary Report 53
Progesterone receptor loss identifies luminal B breast cancer subgroups at higher risk of relapse 52
Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer 52
Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study 52
Correlation of size and focality with prognosis in small breast carcinoma: a single institution case series 52
Abstract P5-07-02: Systematic analysis and modulation of Ki67 interobserver variance in 9069 patients from three clinical trials – How much pathologist concordance is needed for meaningful biomarker results? 51
Microbiopsia mammaria stereotassica. 50
High Ki67 predicts unfavourable outcomes in early breast cancer patients with a clinically clear axilla who do not receive axillary dissection or axillary radiotherapy 50
null 49
Testicular Modification Induced by Low Alcohol Intake in Rat. Morphometric Investigations and bcl-2 Oncogene Expression 49
Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer 49
Accelerated partial breast irradiation with intraoperative electrons: Using GEC-ESTRO recommendations as guidance for patient selection 49
Mesotelioma multicistico benigno del pericardio. Descrizione di un caso 48
Abstract P1-15-06: Lobular histology and partial breast irradiation: To what extent is it a cautionary parameter? 48
Breast cancer subtypes and outcome after local and regional relapse 48
An international study to increase concordance in Ki67 scoring 47
Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes 47
Outcome of special types of luminal breast cancer 47
Primary and secondary angiosarcomas of the breast: A single institution experience 47
Metastatic tumors of the oro-facial tissues: Clear cell renal cell carcinoma. A clinico-pathological study of seven cases 47
Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast 47
Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast 46
Benign multicystic mesothelioma of the pericardium (BMMP). A case report 45
Positive axillary sentinel lymph node: Is axillary dissection always necessary? 45
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial 45
Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome 45
Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know 45
Angiomixoma aggressivo dello scroto. Studio di un caso 44
Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration 44
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 44
Mechanical characterization of human urethra 44
Outcome and medial presentation of breast cancer: European Institute of Oncology experience 43
Analytical validation of a standardized scoring protocol for Ki67: Phase-3 of an international multicenter collaboration 43
Prognostic significance of Ki-67 in node-negative (pN0), triple-negative (TN) breast cancer (BC) 43
Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy 43
Male breast cancer 43
What can the pathologist offer for optimal treatment choice? 43
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer 42
Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: Current and resolving controversies on the basis of the European Institute of Oncology experience 42
HER2-negative (1+) breast cancer with unfavorable prognostic features: To FISH or not to FISH? 42
An international ki67 reproducibility study 41
null 40
Studio delle regioni organizzatrici argirofile del nucleolo (AgNORs) nelle neoformazioni colo-rettali quale indice di malignità biologica. [Argyrophilic nucleolar organizer regions (AgNORs) as malignancy biomarkers in colorectal neoplasms]. 40
Calcified metastatic mediastinal lymph nodes from mucinous breast adenocarcinoma 40
Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration 40
Breast cancer pathology 40
Robotic vs open prostatectomy in a laparoscopically naive centre: A matched-pair analysis 39
Breast cancer subtypes and outcome after local and regional relapse 39
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 39
Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution 39
Central Review of ER, PgR and HER2 in BIG 1-98 Evaluating Letrozole vs. Letrozole Followed by Tamoxifen vs. Tamoxifen Followed by Letrozole as Adjuvant Endocrine Therapy for Postmenopausal Women with Hormone Receptor-Positive Breast Cancer 38
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes 37
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial 37
Immunohistochemically defined subtypes and outcome in occult breast carcinoma with axillary presentation 37
Atypical vascular lesions after radiation therapy for breast cancer: A clinicopathologic study and outcomes of 24 cases 36
Diagnostic and therapeutic management of carcinoma of unknown primary: Histopathological and molecular diagnosis 34
The prognostic role of high Ki-67 in early breast cancer patients who do not receive axillary dissection or axillary radiotherapy 34
Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons 34
Wireless ultrasound-guided vacuum-assisted breast biopsy: Experience in clinical practice at European Institute of Oncology 34
Atypical Ductal Hyperplasia after Vacuum-Assisted Breast Biopsy: Can We Reduce the Upgrade to Breast Cancer to an Acceptable Rate? 34
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy 33
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapy 33
Occasional finding of a carcinoid in a vermiform appendix-like structure inside a mature cystic teratoma of the ovary 33
Adverse prognostic value of peritumoral vascular invasion: is it abrogated by adequate endocrine adjuvant therapy? Results from two International Breast Cancer Study Group randomized trials of chemoendocrine adjuvant therapy for early breast cancer 33
Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel node biopsy. A study of 1228 patients treated in a single institution including 116 patients with isolated tumor cells only in the sentinel lymph nodes 32
LOCOREGIONAL RECURRENCE AFTER CONSERVATIVE SURGERY FOR DUCTAL BREAST CANCER: ROLE OF SURGICAL MARGIN 32
null 28
DCIS and LCIS are confusing and outdated terms. They should be abandoned infavor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN) 28
Totale 5.341
Categoria #
all - tutte 35.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020632 0 0 0 0 0 0 37 37 42 220 138 158
2020/20211.420 138 254 150 170 52 30 59 149 45 158 82 133
2021/2022692 36 25 1 19 55 110 13 36 40 95 52 210
2022/20231.466 154 149 91 147 105 190 50 234 207 20 95 24
2023/2024525 41 84 34 24 51 121 21 42 3 14 35 55
2024/2025633 17 34 159 90 106 214 13 0 0 0 0 0
Totale 5.859